Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
Home
Fabiana da Silva Alves, MS: The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic Medication
Fabiana da Silva Alves, MS: The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic Medication
$
30.00
Fabiana da Silva Alves, MS: The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic Medication quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 41 No. 1 Articles
Tags:
brain-imaging
,
dick-veltman
,
dopaminergic-manipulation
,
fabiana-da-silva-alves
,
fmri
,
martijn-figee
,
md
,
ms
,
negative-symptoms
,
phd
,
phmri
,
prefrontal-hypoactivity
,
schizophrenia-patients
,
schizophrenia-treatment
,
subcortical-hyperactivity
,
therese-van-amelsvoort
,
work-memory
Description
Description
Fabiana da Silva Alves, MS
BRAIN IMAGING
The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical
Antipsychotic Medication
Fabiana da Silva Alves, MS, Martijn Figee, MD, Therese van Amelsvoort, MD, PhD, Dick Veltman, MD, PhD, and Lieuwe de Haan, MD, PhD
PB-41-1-09-Alves
Related products
Trisha Suppes, MD, PhD: Awareness of Metabolic Concerns and Perceived Impact of Pharmacotherapy in Patients with Bipolar Disorder: A Survey of 500 US Psychiatrists
$
30.00
Add to cart
Details
Srinivas G. Rao, MD, PhD: Understanding The Fibromyalgia Syndrome
$
30.00
Add to cart
Details
David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder
$
30.00
Add to cart
Details
Johannes Hamann, MD: How Long do Psychiatrists Wait for Response Before They Switch to Another Antipsychotic?
$
30.00
Add to cart
Details
Page load link
Go to Top